Cargando…

Purified Serum IgG from a Patient with Anti-IgLON5 Antibody Cause Long-Term Movement Disorders with Impaired Dopaminergic Pathways in Mice

Background: Anti-IgLON5 disease is a rare autoimmune disease of the central nervous system. It typically manifests as a chronic condition, characterized by cognitive impairments, movement disorders, and sleep disorders. The mechanisms underlying movement disorders in this disease remain poorly under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yining, Li, Hongxia, Luo, Huoqing, Ni, You, Feng, Yifan, He, Lu, Zhou, Qinming, Hu, Ji, Chen, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526147/ https://www.ncbi.nlm.nih.gov/pubmed/37760924 http://dx.doi.org/10.3390/biomedicines11092483

Ejemplares similares

Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions
por: Landa, Jon, et al.
Publicado: (2023)

Early immunotherapy is highly effective in IgG1/IgG4 positive IgLON5 disease
por: Grüter, Thomas, et al.
Publicado: (2020)

Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions
por: Landa, Jon, et al.
Publicado: (2023)

Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice
por: Ni, You, et al.
Publicado: (2022)

IgLON5 disease responsive to immunotherapy
por: Bonello, Michael, et al.
Publicado: (2017)

Understanding anti-IgLON5 disease
por: Graus, Francesc, et al.
Publicado: (2017)

Subacute encephalitis with recovery in IgLON5 autoimmunity
por: Ramanan, Vijay K., et al.
Publicado: (2018)

Molecular Evolution and Functional Divergence of the IgLON Family
por: Kubick, Norwin, et al.
Publicado: (2018)

Bilateral vestibulopathy in anti-IgLON5 disease
por: Helmchen, Christoph, et al.
Publicado: (2021)

IgLON5 Regulates the Adhesion and Differentiation of Myoblasts
por: Lim, Jeong Ho, et al.
Publicado: (2021)

Immunotherapy improves sleep and cognitive impairment in anti-IgLON5 encephalopathy
por: Brunetti, Valerio, et al.
Publicado: (2019)

Neuropathological criteria of anti-IgLON5-related tauopathy
por: Gelpi, Ellen, et al.
Publicado: (2016)

Ocular Motor Abnormalities in Anti-IgLON5 Disease
por: Macher, Stefan, et al.
Publicado: (2021)

The Role of IgLON Cell Adhesion Molecules in Neurodegenerative Diseases
por: Salluzzo, Marco, et al.
Publicado: (2023)

Anti-IgLON5 disease: a novel topic beyond neuroimmunology
por: Zhang, Yi-ZongHeng, et al.
Publicado: (2022)

Sleep disorder, chorea, and dementia associated with IgLON5 antibodies
por: Simabukuro, Mateus M., et al.
Publicado: (2015)

Isolated dysphagia as initial sign of anti-IgLON5 syndrome
por: Schröder, Jens Burchard, et al.
Publicado: (2016)

IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients
por: Honorat, Josephe A., et al.
Publicado: (2017)

Case Report: Neuropsychological Findings in IgLON5 Antibody Disorder
por: El Shazly, Jasmin, et al.
Publicado: (2021)

Promoter-Specific Expression and Genomic Structure of IgLON Family Genes in Mouse
por: Vanaveski, Taavi, et al.
Publicado: (2017)

Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome
por: Sabater, Lidia, et al.
Publicado: (2016)

Spatiotemporal expression of IgLON family members in the developing mouse nervous system
por: Fearnley, Sydney, et al.
Publicado: (2021)

Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives
por: Madetko, Natalia, et al.
Publicado: (2022)

Bilateral horizontal gaze palsy due to Anti-IgLON5 disease
por: Bhatti, M Tariq
Publicado: (2022)

Trigeminal Nerve Involvement in Bulbar-Onset Anti-IgLON5 Disease
por: Cluse, Florent, et al.
Publicado: (2023)

Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis
por: Hansen, Niels, et al.
Publicado: (2020)

Anti-IgLON5 disease complicated with rectal adenocarcinoma: a case report
por: Li, Yi, et al.
Publicado: (2023)

Das Anti-IgLON5-Syndrom in der klinischen Neurologie – zwei Fallberichte
por: Niederschweiberer, Johanna, et al.
Publicado: (2022)

Corrigendum: Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis
por: Hansen, Niels, et al.
Publicado: (2020)

Improvement in mild anti-IgLON5 encephalopathy without immunotherapy: a case report
por: Wang, Yuting, et al.
Publicado: (2021)

Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease
por: Shambrook, Pauline, et al.
Publicado: (2021)

IgLON4 Regulates Myogenesis via Promoting Cell Adhesion and Maintaining Myotube Orientation
por: Lim, Jeong Ho, et al.
Publicado: (2022)

Anti‐IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the Literature
por: Grossauer, Anna, et al.
Publicado: (2022)

Anti-IgLON5 disease exacerbated by asymptomatic SARS-CoV-2 infection
por: Li, Xiaoyang, et al.
Publicado: (2023)

P014 IgLON5 Disease – A Review of 2 Cases and Sleep Manifestations
por: Banks, J, et al.
Publicado: (2022)

IgLON5-Associated Encephalitis With Atypical Brain Magnetic Resonance Imaging and Cerebrospinal Fluid Changes
por: Montagna, Massimiliano, et al.
Publicado: (2018)

Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature
por: Nissen, Mette Scheller, et al.
Publicado: (2019)

Anti-IgLON5 Disease: A New Bulbar-Onset Motor Neuron Mimic Syndrome
por: Werner, Jana, et al.
Publicado: (2021)

Neuroimaging Findings in a Patient with Anti-IgLON5 Disease: Cerebrospinal Fluid Dynamics Abnormalities
por: Urso, Daniele, et al.
Publicado: (2022)

HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease
por: Gaig, Carles, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p88o4jag0jodjvcjmfvlupof8v